ChemicalBook > CAS DataBase List > Rifapentine

Rifapentine

Product Name
Rifapentine
CAS No.
61379-65-5
Chemical Name
Rifapentine
Synonyms
ktc1;dl473;r-773;mdl473;Priftin;Prifitin;Rifapenti;Rifapentin;PIFAPENTINE;RIFAPENTINE
CBNumber
CB6381080
Molecular Formula
C47H64N4O12
Formula Weight
877.03
MOL File
61379-65-5.mol
More
Less

Rifapentine Property

Melting point:
179-1800C
Boiling point:
969.3±65.0 °C(Predicted)
Density 
1.35±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Store in freezer, under -20°C
solubility 
methanol: soluble2mg/mL, clear, red to red-brown
form 
powder
pka
4.81±0.70(Predicted)
color 
Red
More
Less

Safety

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26
WGK Germany 
3
RTECS 
JQ0902000
HS Code 
2941.90.3000
Toxicity
LD50 in mice (mg/kg): >2000 orally; 750 i.p. (Cricchio); LD50 in mice (mg/kg): 3300 orally; 710 i.p. (Aroli)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
R0533
Product name
Rifapentine
Purity
≥93%
Packaging
25mg
Price
$392
Updated
2024/03/01
Sigma-Aldrich
Product number
R0533
Product name
Rifapentine
Purity
≥93%
Packaging
100mg
Price
$1310
Updated
2024/03/01
TCI Chemical
Product number
R0198
Product name
Rifapentine
Packaging
100MG
Price
$222
Updated
2024/03/01
TCI Chemical
Product number
R0198
Product name
Rifapentine
Packaging
500MG
Price
$667
Updated
2024/03/01
Cayman Chemical
Product number
20307
Product name
Rifapentine
Purity
≥98%
Packaging
50mg
Price
$95
Updated
2024/03/01
More
Less

Rifapentine Chemical Properties,Usage,Production

Description

Rifapentine is a broad spectrum antibiotic highly active against Gram-positive bacteria and Neisseria gonorrhoea. It is reported to be 10 times more active than the structurally related rifampicin against Mycobacrerim fuberculosis. Unlike rifampicin the bioavailability of rifapentine is significantly increased when administered after a meal.

Chemical Properties

Crystalline Solid

Originator

Shanghai No. 5 Factory (China)

Uses

antibacterial (tuberculostatic);'inhibits DNA-dependent RNA polymerase in susceptible strains of Mycobacterium tuberculosis

Uses

PDE5 inhibitor for erectile dysfunction A semisynthetic ansamycin antibiotic, cyclopentyl derivative of Rifamycin. Treatment of pulmonary tuberculosis

Uses

Semi-synthetic rifamycin. Antibacterial (tuberculostatic)

Definition

ChEBI: Rifapentine is a N-alkylpiperazine, a N-iminopiperazine and a member of rifamycins. It has a role as an antitubercular agent and a leprostatic drug.

Indications

Rifapentine is an analogue of rifampin that is active against M. tuberculosis and M. avium. Rifapentine’s mechanism of action, cross-resistance, hepatic induction of P450 enzymes, drug interactions, and toxic profile are similar to those of rifampin. It has been used in the treatment of tuberculosis caused by rifampinsusceptible strains.

brand name

Priftin (Sanofi Aventis);Rifampin.

Antimicrobial activity

Activity is similar to that of rifampicin, but it is more active against atypical mycobacteria, especially the M. avium complex (MIC <0.06–0.5 mg/L). It has good activity on staphylococci and streptococci (MIC 0.01–0.5 mg/L), L. monocytogenes and Brucella spp.; less against Enterococcus faecalis (MIC 1–4 mg/L). Bacteroides spp. are inhibited by 0.5–2 mg/L. Gram-negative cocci are susceptible and, although some Gram-negative bacilli are inhibited by 4–32 mg/L, most are resistant.

Hazard

Moderately toxic by ingestion.

Pharmaceutical Applications

An analog of rifampicin in which a cyclopentyl group is substituted for a methyl group on the piperazine ring. It is available for oral administration.

Mechanism of action

Because relapse and the emergence of resistant strains of bacteria are associated with poor patient compliance, reduced dosing is expected to increase compliance. Initial clinical studies actually showed that the relapse rates in patients treated with rifapentine (10%) were higher than those in the patients treated with RIF (5%). It was found that poor compliance with the nonrifamycin antituberculin agents was responsible for the increased relapse.

Pharmacokinetics

Oral absorption:c. 70%
Cmax600 mg oral :12 mg/L after 5 h
Plasma half-life:13 h
Volume of distribution:1.5 L/kg
Plasma protein binding:97%
absorption
The absolute oral bioavailability of rifapentine has not been determined. The relative bioavailability of capsules (with an oral solution as reference) is 70%. Food increases absorption: a 600 mg dose taken after a meal gives Cmax and AUC values 44% higher than under fasting conditions. The extended halflife provides therapeutic concentrations for at least 72 h after administration, allowing less frequent dosing.
Distribution
Animal data suggest that it is well distributed in the body, with tissue concentrations exceeding the plasma concentration, except in bone, testes and brain. The ratio of intracellular:extracellular concentration in macrophages was estimated as 24:1.
Metabolism
The main metabolite is an antimicrobially active 25-desacetyl derivative. Although it induces liver cytochromes it is not an inducer of its own metabolism, which is mediated by an esterase. The peak concentration of 25-desacetyl rifapentine is about one-third of that of the unchanged drug, and is attained after about 11 h.
excretion
The main route of elimination is through the bile. In healthy volunteers about 70% of a 600 mg dose of 14C rifapentine was recovered in the feces, and less than 17% in the urine. There is evidence of enterohepatic recycling in humans.

Clinical Use

Tuberculosis (in combination with other antituberculosis drugs)

Side effects

Signs of teratogenic effects and fetal toxicity have been observed when administered during pregnancy to rats and rabbits. Rifapentine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
The most common adverse effect observed in combinations with other antimycobacterial agents was hyperuricemia, most probably due to pyrazinamide. Effects likely to be due to rifapentine were neutropenia (3.7% of patients) and hepatitis (increased transaminases in 1.6% of patients).

in vitro

the activities of rifampin and rifapentine against mycobacterium tuberculosis residing in human monocytederived macrophages were determined. the mic and mbc of rifapentine for intracellular bacteria were two- to four-fold lower than those of rifampin. for extracellular bacteria, this difference was less noticeable. [1].

in vivo

once-a-week exposure to rifapentine concentrations equivalent to that attained in blood after one 600-mg dose resulted during the first week in a dramatic decline in the number of bacteria, and such decline was maintained at a minimal level for a period of four weeks. the prolonged effect of rifapentine found may be associated with high ratios of intracellular accumulation, which were four- to fivefold higher than those found for rifampin [1].

References

[1] mor n, simon b, mezo n, heifets l. comparison of activities of rifapentine and rifampin against mycobacterium tuberculosis residing in human macrophages. antimicrob agents chemother. 1995 sep;39(9):2073-7.
[2] temple me, nahata mc. rifapentine: its role in the treatment of tuberculosis. ann pharmacother. 1999 nov;33(11):1203-10.

More
Less

Rifapentine Suppliers

Hubei widely chemical technology Co., Ltd.
Tel
027-83989310 18627915365
Fax
027-83989310
Email
2658488909@qq.com
Country
China
ProdList
1297
Advantage
58
Jiangxi ravel Biotechnology Co.,Ltd
Tel
185-0276-2003 18502762003;
Email
435918333@qq.com
Country
China
ProdList
2312
Advantage
58
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6005
Advantage
61
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10186
Advantage
62
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32321
Advantage
50
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768850
Email
1791901229@qq.com
Country
China
ProdList
8836
Advantage
52
Wuhan Fortuna Chemical Co., Ltd
Tel
027-59207852 13308628970
Fax
QQ3130921841
Email
buy@fortunachem.com
Country
China
ProdList
2866
Advantage
58
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com
Country
China
ProdList
4727
Advantage
58
More
Less

View Lastest Price from Rifapentine manufacturers

Hebei Weibang Biotechnology Co., Ltd
Product
Rifapentine 61379-65-5
Price
US $1.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
10 mt
Release date
2024-11-20
Hebei Chuanghai Biotechnology Co,.LTD
Product
Rifapentine 61379-65-5
Price
US $80.70/kg
Min. Order
10kg
Purity
99%
Supply Ability
10000kg
Release date
2024-08-21
Hebei Mojin Biotechnology Co., Ltd
Product
Rifapentine 61379-65-5
Price
US $0.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
50000KG/month
Release date
2023-07-03

61379-65-5, RifapentineRelated Search:


  • rifamycinaf/acpp
  • 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin
  • Rifapentine(Priftin)
  • PIFAPENTINE
  • antibioticdl473it
  • dl473
  • ktc1
  • mdl473
  • r-773
  • 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)-rifamyci
  • 3-(4-cyclopentyl-1-piperazinyl)iminomethylrifamycinsv
  • RIFAPENTINE
  • Rifapention
  • 3 & 4-NONENES & 4-NONANOL
  • Cyclopentylrifampicin
  • Prifitin
  • Priftin
  • Rifapenti
  • 3-[[(4-Cy-dopentyl-1piperazinyl)imino]methyl]rifamycin
  • Rifapentin
  • Rifamycin, 3-(((4-cyclopentyl-1-piperazinyl)imino)methyl)
  • 3-[(4-Cyclopentylpiperazino)iminomethyl]rifamycin
  • Rifapentinum
  • Rifapentina
  • (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione
  • Rifapentine USP/EP/BP
  • Rifapentine (DL 473)
  • Rifapentine, ≥98% (HPLC)
  • 61379-65-5
  • 6167-65-5
  • C47H64N4O12
  • API
  • Priftin
  • Antibiotics
  • Chiral Reagents
  • Active Pharmaceutical Ingredients
  • Rifapentine
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • 61379-65-5